---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-052675"
form_type: "8-K"
ticker: "NOTV"
cik: "0000720154"
company_name: "Inotiv, Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:31:50.656415+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Inotiv prelim Q4 revenue $137.5-138.5M; full year $512.5-513.5M; DSA awards up 60% YoY

## Summary
- Preliminary Q4 FY2025 revenue $137.5-138.5M, improving over prior year; full year $512.5-513.5M.
- DSA book-to-bill ~1.08x in Q4 and ~1.05x for FY2025; backlog $138.0M at Sept 30, 2025.
- DSA contract awards in Q4 increased 60% year-over-year.
- Full fiscal 2025 audited results expected in early December 2025.
- CEO Robert Leasure Jr. to present at Jefferies Global Healthcare Conference Nov 18 at 6:00 AM ET.

## SEC filing metadata
- accession: 0001628280-25-052675
- form_type: 8-K
- ticker: NOTV
- cik: 0000720154
- company_name: Inotiv, Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/720154/000162828025052675/0001628280-25-052675-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/720154/000162828025052675/notv-20251117.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-052675
- JSON: https://secwatch.observer/filing/0001628280-25-052675.json
- Plain text: https://secwatch.observer/filing/0001628280-25-052675.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.